Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22787,1367,1.20 [1.10-1.31],7.180058652866588e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22368,3368,1.13 [1.07-1.20],1.916633529230548e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22344,3408,1.25 [1.18-1.32],2.6906652925426948e-15
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16227,2212,1.27 [1.18-1.36],1.20882951131168e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Lung cancer and mesothelioma,15439,337,1.92 [1.66-2.23],4.52585559479409e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18160,214,1.59 [1.32-1.91],9.70275849633866e-07
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23113,267,1.48 [1.22-1.80],6.36477187689729e-05
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17022,300,1.70 [1.43-2.02],2.084881119549005e-09
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17089,367,1.46 [1.24-1.72],7.602996391516259e-06
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21762,5040,1.12 [1.07-1.17],5.044384820197398e-06
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22294,20,3.46 [2.01-5.98],8.187406698305018e-06
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18299,1577,1.26 [1.16-1.36],4.13141109717411e-08
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17499,777,1.28 [1.14-1.44],2.5449859548198137e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21983,270,1.53 [1.28-1.83],2.1457410589911862e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21955,242,1.76 [1.47-2.10],7.459932874056004e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,13569,2245,1.17 [1.09-1.26],7.499690621778509e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21399,2565,1.19 [1.12-1.27],1.224878076486652e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22867,1290,1.34 [1.23-1.46],5.4430296157716675e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14282,177,2.28 [1.88-2.78],1.3570054756352168e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14270,165,1.61 [1.28-2.01],3.5092742658498536e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypotension,23025,1202,1.30 [1.19-1.43],1.032462624000202e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21536,2679,1.15 [1.08-1.23],1.9398678416042103e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22749,632,1.30 [1.15-1.47],4.462330319692444e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22460,1037,1.28 [1.16-1.41],1.0101432675890964e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19756,899,1.31 [1.18-1.46],4.865304381127867e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19250,1212,1.32 [1.20-1.45],1.1621079847926956e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22274,561,1.55 [1.37-1.75],4.206436955039841e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22538,351,2.15 [1.86-2.48],1.4823799376644459e-25
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22183,515,1.53 [1.35-1.74],6.494776049140423e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23108,690,1.32 [1.17-1.50],7.142306247819285e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22536,349,2.14 [1.86-2.48],2.2301812964567402e-25
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22733,722,1.28 [1.14-1.44],3.347406933891507e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19913,943,1.24 [1.12-1.38],4.81026035811164e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Any mental disorder,22506,3536,1.19 [1.13-1.25],1.1140005412406847e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Smoking dependency,22541,1490,1.37 [1.28-1.47],1.1128398814905961e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20784,1814,1.30 [1.23-1.38],4.1571608267613784e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Bronchiectasis,20160,281,1.68 [1.41-2.00],9.459546406474329e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22353,2474,1.31 [1.23-1.40],1.6722141842204892e-17
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22953,1264,1.44 [1.33-1.56],3.999506983988864e-19
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21223,5124,1.18 [1.13-1.23],3.3942599953788494e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Early onset COPD,21985,296,1.53 [1.31-1.78],5.4739840478926094e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Emphysema,20218,339,1.96 [1.71-2.25],5.126743869347614e-22
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22269,323,2.83 [2.47-3.24],8.055445078388657e-51
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22928,2081,1.33 [1.24-1.43],4.301145478896613e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22296,350,2.66 [2.33-3.04],1.1817109790062544e-46
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Later onset COPD,22142,968,1.41 [1.28-1.54],1.1709698688560228e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22904,959,1.39 [1.25-1.53],1.8053433731682047e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,22898,2121,1.32 [1.23-1.41],1.1620917418658742e-15
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23078,431,2.34 [2.06-2.65],2.9336586779063384e-39
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23051,1351,1.36 [1.25-1.48],1.0914946053235764e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pleural effusion,21854,1077,1.29 [1.17-1.42],2.0171307543583774e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22670,1823,1.34 [1.25-1.44],2.9394088021119045e-15
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22889,944,1.39 [1.25-1.54],1.9212302532635187e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22198,1818,1.22 [1.13-1.31],2.8086302379739485e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21875,1495,1.22 [1.12-1.33],4.328540337447044e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22869,2747,1.17 [1.10-1.25],8.349936104955546e-07
